Loading insider details...
Beta
Latest Form 4 (Aug 14, 2026): Exercise/Conversion of 1,250 SUPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 1,250 | n/a |
| Jul 31, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,250 | n/a |
| Mar 10, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 3,000 | n/a |
| Mar 3, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 3,000 | n/a |
| Feb 26, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 2,500 | n/a |
| Feb 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,125 | n/a |
| Feb 20, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 17,500 | n/a |
| Aug 26, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sale | 11,780 | $524.1K |
| Mar 11, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 2,000 | n/a |
| Mar 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Tax Withholding | 276 | $9.1K |